Who Is Suitable for Regenerative Therapy? A Complete Guide to PRP and Prolotherapy Indications and Contraindications

Knee degeneration, shoulder impingement, plantar fasciitis, chronic neck and shoulder pain — you may have heard the terms "PRP" or "prolotherapy" from a clinic or online. But the real question most patients have is: Is this treatment actually right for me?

Regenerative injection therapy is not a catch-all pain solution, and not everyone will benefit equally. Understanding the indications map and contraindications allows your physician to make the most evidence-based, individualized recommendation for you.

Two Core Approaches in Regenerative Therapy

Before discussing who is suitable, it helps to clarify the two primary methods:

PRP (Platelet-Rich Plasma): Blood is drawn from your own vein, then centrifuged to concentrate platelets at levels far above whole blood. The resulting plasma is injected into the affected tissue. Platelets release growth factors (including PDGF, TGF-β, and VEGF) that activate local repair responses, stimulate angiogenesis (new blood vessel formation), and promote tissue regeneration.

Prolotherapy (Proliferative Injection Therapy): A hypertonic dextrose solution is injected into ligament or tendon attachment points, or joint spaces. The controlled local irritation triggers a regulated inflammatory response, which initiates the body's own tissue repair cascade and strengthens structural integrity over time.

Key Insight: Both approaches share a core principle — "let the body repair itself, rather than simply suppressing symptoms." But if the body's repair capacity is itself compromised (such as in immune deficiency or blood disorders), this premise breaks down and careful evaluation is essential.

Indications Map: What Conditions Are Typically Suitable?

Regenerative therapy has meaningful evidence support primarily in four areas: chronic tendon and ligament injuries, early-to-mid-stage degenerative joint disease, perineural adhesions (nerve entrapment), and myofascial trigger points.

Key Insight: "Suitable indication" does not equal "guaranteed outcome." Systematic reviews of PRP in knee osteoarthritis show an overall trend of improvement, but individual tissue response varies considerably. Each patient's tissue environment differs — evaluation is the starting point, not the endpoint. See our PRP Evidence Update for Degenerative Knee Osteoarthritis for a detailed evidence summary.

Who Should NOT Receive Regenerative Therapy?

Medical contraindications fall into two categories: absolute (treatment should not proceed) and relative (individual evaluation required; risks may be elevated but treatment may still be appropriate in select cases).

Absolute Contraindications (Do Not Proceed)

• Active infection: Local skin infection, septic arthritis, or systemic infection (sepsis) — injection may spread the infection.
• Known or suspected malignancy: Growth factors in PRP may theoretically promote tumor cell proliferation, particularly near metastatic lesions. Safety data is insufficient; avoid.
• Severe platelet dysfunction or blood disorder: Thrombocytopenia (platelet count < 50,000/μL), hemophilia, or clotting factor deficiency — blood draw and tissue injection both carry elevated risk.
• Irreversible anticoagulant therapy that cannot be paused: Patients on warfarin with high discontinuation risk face significantly elevated injection-site bleeding risk.

Relative Contraindications (Individual Evaluation Needed)

Common Misconceptions

"I'm too old for PRP to work."

Age affects platelet function to some degree, but is not an exclusion criterion. Clinical trials in the 50–75 age group for knee osteoarthritis still demonstrate functional improvement. The focus should be on tissue evaluation (degree of degeneration, blood flow quality) rather than chronological age.

"I have hypertension and diabetes — does that disqualify me?"

Stable, well-controlled chronic conditions (hypertension, type 2 diabetes) are generally not contraindications. It's poorly controlled blood sugar or blood pressure that impairs repair efficiency — this falls under "individual evaluation required," not "absolutely excluded."

"Do I need to stop supplements before treatment?"

High-dose Omega-3 may mildly affect platelet aggregation; discontinuing 3–5 days before the procedure is advisable. Standard vitamin C supplementation does not have a clinically significant effect.

Why Ultrasound Guidance Matters for Safety

The precision of regenerative injection directly determines both efficacy and safety. "See it before you treat it" — ultrasound-guided injection means:

1. Confirming needle tip position: Avoiding inadvertent entry into blood vessels, nerves, or incorrect tissue planes, ensuring the injectate reaches the target structure
2. Real-time tissue assessment: Pre-injection imaging can identify occult infection, joint effusion, or suspicious lesions that may be invisible on plain X-ray
3. Reducing blind injection uncertainty: Especially in deep structures (sacroiliac joint, quadratus lumborum) or perineural injections, image guidance significantly reduces complication risk compared to landmark-based technique

See Trigger Point Injection: Comparing PRP, Dextrose, and Dry Needling for an analysis of ultrasound guidance in myofascial injection.

The Evaluation Process: How Is Suitability Assessed?

Determining whether regenerative therapy is right for you involves multiple layers:

1. Chief complaint and history: Pain location, duration, treatments already tried (rehabilitation, medications, corticosteroid injection history)
2. Physical assessment: Functional testing, tender point mapping, range of motion evaluation
3. Imaging evaluation: Ultrasound (preferred) or MRI to confirm tissue injury severity; X-ray for joint degeneration staging
4. Baseline bloodwork (before PRP): Platelet count and coagulation function to confirm safe PRP preparation
5. Medication review: Anticoagulants, NSAIDs, cancer therapies, immunosuppressants

See Knee Osteoarthritis Stages and Symptoms for an example of how staging evaluation guides treatment decisions.

If your symptoms match the indications above but you also have relative contraindications, the best next step is a consultation — where a complete picture of your current health status guides the recommendation.

A Final Word

Regenerative therapy outcomes depend heavily on selecting the right patient, the right timing, and the right approach. No regenerative treatment "works for everyone," and no contraindication is a permanent exclusion — every evaluation is about finding the most appropriate path given your current tissue state.

Results vary by individual tissue response. Evaluation and consultation are the first step to understanding your specific candidacy. Visit our Regenerative Therapy Service Overview to learn more about the clinic's regenerative medicine services.